Safety, Tolerability, Immunogenicity and Protective Efficacy Against Naturally-Transmitted Malaria in Eastern Indonesia of Two Plasmodium Falciparum Sporozoite Vaccines, Sanaria PfSPZ Vaccine and Sanaria PfSPZ-CVac: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial in Healthy Indonesian Adults
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; Malaria vaccine live unattenuated-Sanaria (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanaria
- 30 May 2019 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.
- 30 May 2019 Planned primary completion date changed from 1 Apr 2020 to 1 Apr 2021.
- 30 May 2019 Planned initiation date changed from 1 Mar 2019 to 1 Oct 2019.